338 related articles for article (PubMed ID: 32981634)
1. Histone deacetylases as targets in autoimmune and autoinflammatory diseases.
Hamminger P; Rica R; Ellmeier W
Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634
[TBL] [Abstract][Full Text] [Related]
2. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of HDACs and their therapeutic implications in cancer.
Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase function in CD4
Ellmeier W; Seiser C
Nat Rev Immunol; 2018 Oct; 18(10):617-634. PubMed ID: 30022149
[TBL] [Abstract][Full Text] [Related]
5. The acetyl code in rheumatoid arthritis and other rheumatic diseases.
Angiolilli C; Baeten DL; Radstake TR; Reedquist KA
Epigenomics; 2017 Apr; 9(4):447-461. PubMed ID: 28102705
[TBL] [Abstract][Full Text] [Related]
6. Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapy.
Olzscha H; Sheikh S; La Thangue NB
Crit Rev Oncog; 2015; 20(1-2):1-17. PubMed ID: 25746101
[TBL] [Abstract][Full Text] [Related]
7. Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy.
Singh AK; Bishayee A; Pandey AK
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29882797
[TBL] [Abstract][Full Text] [Related]
8. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Expression and Role of Histone Acetylation and Deacetylation in Dental Pulp Cells.
Yamauchi Y; Duncan HF
Methods Mol Biol; 2023; 2588():279-293. PubMed ID: 36418694
[TBL] [Abstract][Full Text] [Related]
10. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.
Wahi A; Jain P; Sinhari A; Jadhav HR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):675-702. PubMed ID: 37615708
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
[TBL] [Abstract][Full Text] [Related]
12. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of HDACs in Tumorigenesis.
Hadley M; Noonepalle S; Banik D; Villagra A
Methods Mol Biol; 2019; 1983():279-307. PubMed ID: 31087305
[TBL] [Abstract][Full Text] [Related]
14. HDACs as an emerging target in endocrine tumors: a comprehensive review.
Klieser E; Neumayer B; Di Fazio P; Mayr C; Neureiter D; Kiesslich T
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):143-154. PubMed ID: 36872882
[TBL] [Abstract][Full Text] [Related]
15. Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis.
Gray SG; Dangond F
Epigenetics; 2006; 1(2):67-75. PubMed ID: 17998807
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention.
Ganai SA
Curr Drug Targets; 2018; 19(6):593-601. PubMed ID: 27231104
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
Ramaiah MJ; Tangutur AD; Manyam RR
Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
[TBL] [Abstract][Full Text] [Related]
18. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
19. Prospects: histone deacetylase inhibitors.
Dokmanovic M; Marks PA
J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937
[TBL] [Abstract][Full Text] [Related]
20. The role of histone deacetylases in embryonic development.
Dsilva P; Pai P; Shetty MG; Babitha KS
Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
